Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ENLV will decline by -19.52% over the next 2 Weeks and hit $0.39 by Wednesday, July 22, 2026. In that time frame, ENLV's share price is expected to range between $0.34 and $0.43.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 22, 2026 | 0.34 | 0.39 | 0.43 |
| Jul 21, 2026 | 0.33 | 0.37 | 0.41 |
| Jul 20, 2026 | 0.37 | 0.41 | 0.45 |
| Jul 17, 2026 | 0.38 | 0.42 | 0.46 |
| Jul 16, 2026 | 0.39 | 0.43 | 0.47 |
| Jul 15, 2026 | 0.41 | 0.44 | 0.48 |
| Jul 14, 2026 | 0.39 | 0.43 | 0.46 |
| Jul 13, 2026 | 0.43 | 0.47 | 0.51 |
| Jul 10, 2026 | 0.43 | 0.47 | 0.51 |
| Jul 9, 2026 | 0.45 | 0.49 | 0.52 |
ENLV shares rose +2.67% in Thursday, July 9, 2026's trading session, rising from a previous close of $7.21 to move at $7.40. The stock demonstrated notable intraday movement (see ENLV's key stats for a full breakdown), fluctuating between $6.80 and $7.64, a +12.35% trading range. While recent weeks have seen some volatility, ENLV has managed to secure a -15.02% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 98.16K shares changing hands, 43.7K more than the previous session. This amounted to $726.41K in total market activity.
Will ENLV Continue Its Downward Trend?
According to analyst ratings and projections for ENLV, Enlivex Therapeutics Ltd. shares are anticipated to decrease by -1,617.34%, potentially reaching $0.43 per share by July 22, 2026. Short-term technical indicators currently suggest a neutral sentiment for ENLV. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 9 positive trading days within the past 30 sessions. Based on the ENLV stock forecast, now is not the best time to buy ENLV stock because its current trading price is +1,813.63% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ENLV covering social and institutional perspectives.
ENLV Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ENLV's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 21.94% to 30.03%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 39.06%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 43.54%, maintains a neutral outlook for the long term. Insights into ENLV's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Enlivex Therapeutics Short-Term Forecasts
ENLV Forecast For Next 5 Days
Our algorithm anticipates Enlivex Therapeutics (ENLV) stock could hit $0.40 by Jul 16, 2026. This represents a -94.63% rise from today's price, following a +2.87% change over the past five days.
ENLV Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Enlivex Therapeutics Ltd. (ENLV) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.35, which would mean a -95.27% decrease from the current price of $7.40. Projections for this period range from a high of $0.47 to a low of $0.24.
ENLV Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Enlivex Therapeutics's price over the next three months point to a drop. ENLV stock is expected to peak at $3.59 on Aug 05, 2026 before potentially dipping to $1.87 on Sep 10, 2026. On average, ENLV is likely to trade around $2.75 in the coming 90 days.
Enlivex Therapeutics Stock Forecast 2025
Based on our predictive models, Enlivex Therapeutics (ENLV) is expected to trade between $1.20 and $3.59 throughout 2026. This would result in an average price of $2.43, potentially offering investors a -67.16% return from current levels.
Enlivex Therapeutics Ltd. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Enlivex Therapeutics Ltd. (ENLV) is positioned to show a strong performance in July 2026. The price is predicted to move between $2.66 and $3.41, settling at an average of $3.11. This could translate to a -57.97% loss.
August 2026
Based on current market signals, Enlivex Therapeutics Ltd. is projected to trend august 2026. We forecast a trading range from $2.11 to $3.59, with a likely average price of $2.85. Investors could expect a potential return of -61.49%.
September 2026
Our predictive algorithms indicate Enlivex Therapeutics Ltd. stock may see a shift in September 2026. The expected range spans $1.87–$3.07, with an average target of $2.44. This represents a cautious outlook and a possible loss of -67.03%.
October 2026
Analyzing established trends, Enlivex Therapeutics Ltd. looks set to move in October 2026. Projections place the stock between $1.42 and $2.63, averaging around $2.29. This suggests a -69.05% loss from current levels.
November 2026
Market indicators suggest Enlivex Therapeutics Ltd. could experience notable changes during November 2026. Prices could fluctuate within $1.24 to $2.11, with a midpoint forecast of $1.87. The stock might deliver a -74.73% loss.
December 2026
Forecasting for December 2026, models estimate that Enlivex Therapeutics Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $1.20 and $2.71, averaging $2.15. This signals a cautious trajectory with potential returns around -70.95%.
January 2027
According to our latest forecast models, Enlivex Therapeutics Ltd. (ENLV) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.58 and $2.79, settling at an average of $2.21. This could translate to a -70.14% loss.
February 2027
Based on current market signals, Enlivex Therapeutics Ltd. is projected to trend february 2027. We forecast a trading range from $0.33 to $2.36, with a likely average price of $2.17. Investors could expect a potential return of -70.68%.
March 2027
Our predictive algorithms indicate Enlivex Therapeutics Ltd. stock may see a shift in March 2027. The expected range spans $0.00–$2.50, with an average target of $2.81. This represents a cautious outlook and a possible loss of -62.03%.
April 2027
Analyzing established trends, Enlivex Therapeutics Ltd. looks set to move in April 2027. Projections place the stock between $0.00 and $2.09, averaging around $1.63. This suggests a -77.97% loss from current levels.
May 2027
Market indicators suggest Enlivex Therapeutics Ltd. could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $1.22, with a midpoint forecast of $1.56. The stock might deliver a -78.92% loss.
June 2027
Forecasting for June 2027, models estimate that Enlivex Therapeutics Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.91, averaging $1.18. This signals a cautious trajectory with potential returns around -84.05%.
July 2027
According to our latest forecast models, Enlivex Therapeutics Ltd. (ENLV) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $0.65, settling at an average of $1.23. This could translate to a -83.38% loss.
ENLV's history of dividends and stock splits also plays a role in long-term investor confidence.

